Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Paul D. Boucher"'
Publikováno v:
Journal of Cancer Therapy. :1190-1202
Background: Gap junctions enable small molecules to diffuse between adjacent cells and have been associated with greater cytotoxicity of radiation and anti-cancer drugs. We investigated whether this gap junctional intercellular communication (GJIC) a
Autor:
Tico S. Thepsourinthone, Paul D. Boucher, Brendon Ladd, Sheryl A. Flanagan, Donna S. Shewach, John A. Secrist, Mike M. Im, Jessica J. O’Konek
Publikováno v:
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 684:1-10
Nucleoside analogs are efficacious cancer chemotherapeutics due to their incorporation into tumor cell DNA. However, they exhibit vastly different antitumor efficacies, suggesting that incorporation produces divergent effects on DNA replication. Here
Publikováno v:
Cancer gene therapy
Suicide gene therapy with herpes simplex virus thymidine kinase and ganciclovir is notable for producing multi-log cytotoxicity in a unique pattern of delayed cytotoxicity in S-phase. Because hydroxyurea, a ribonucleotide reductase inhibitor that act
Publikováno v:
Cancer Research. 66:3845-3851
Suicide gene therapy with the herpes simplex virus thymidine kinase (HSV-TK) cDNA and ganciclovir can elicit cytotoxicity to transgene-expressing and nonexpressing bystander cells via transfer of ganciclovir phosphates through gap junctions. HeLa cel
Publikováno v:
Cancer Research. 66:3230-3237
The combination of cytosine deaminase (CD) and herpes simplex virus thymidine kinase (HSV-TK) suicide gene protocols has resulted in enhanced antitumor activity in cultured tumor cells and animal models. In this study, we show that concurrent additio
Autor:
Paul D. Boucher, Donna S. Shewach
Publikováno v:
Molecular Therapy. 12:1064-1071
To improve bystander cell killing with HSV-TK/GCV, we have utilized dFdCyd to reduce endogenous dGTP, which competes with GCVTP for incorporation into DNA. In this study we demonstrate the ability of dFdCyd to enhance GCV-mediated bystander cytotoxic
Autor:
Martha J. Fernstrom, Randall J. Ruch, Lucas D. Koffler, Paul D. Boucher, Donna S. Shewach, George A. Abou-Rjaily
Publikováno v:
Experimental and Molecular Pathology. 73:54-60
Gap junctional intercellular communication and expression of gap junction proteins (connexins) are decreased frequently in neoplastic cells including human ovarian carcinoma cells. In order to test the hypothesis that these changes contribute to the
Publikováno v:
Gene Therapy. 9:1023-1030
We have previously demonstrated with several cell lines in vitro that hydroxyurea (HU) synergistically enhances ganciclovir (GCV)-mediated cytotoxicity in bystander cells. In this study, we evaluated the role of DNA synthesis inhibition on enhanced b
Autor:
Paul D. Boucher, Blaine W. Robinson, Donna S. Shewach, Anna L. Blobaum, Laura Zerbe, William B. Parker, Jennifer L. Vuletich, John A. Secrist, Patrick J. Murphy
Publikováno v:
Human Gene Therapy. 13:543-551
Ganciclovir (GCV) is widely used as a prodrug for selective activation in tumor cells expressing herpes simplex virus thymidine kinase (HSV-TK) because of its ability to induce multi-log cytotoxicity to HSV-TK-expressing as well as nonexpressing byst
Autor:
Jeannie Price, Mitchell D. Smith, Michelle R Petrak, Latisha Carter, Elizabeth Blachly-Dyson, B. McCauley Roy, Gowri Reddy, Michael Forte, Kenneth N. Barton, Keith Verner, Paul D. Boucher
Publikováno v:
Journal of Biological Chemistry. 270:28331-28336
Various point mutations of lysyl residues in yeast mitochondrial porin (283 residues) were tested for their ability to assemble in vitro into the outer membranes of intact yeast mitochondria. Assembly was evaluated by protection from proteinases. The